AOA Dx
Blood Test for Early Detection of Ovarian Cancer
Healthcare
Diagnostics
Women's Health
About
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
Build your own investing agent
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlistFounders (3)
Details
Status
Active
Stage
Early
Team Size
25
Regions
United States of America, America / Canada, Remote, Partly Remote